SR

Suresh Ramprabhu Bhosale

Active Director Director DIN 11080901
DIN 11080901 First appointment Apr 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Ramprabhu Bhosale

Data last updated:

Suresh Ramprabhu Bhosale is a Director at Synmol Biosciences Private Limited (since 2025). The company operates in Chemicals.

DIN 11080901
Primary Designation Director
Industry Chemicals
First Appointment 29 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synmol Biosciences Private Limited U20299PN2025PTC241338
Director29 Apr 20252025Active

Board colleagues of Suresh Ramprabhu Bhosale

Directorship timeline

Open interactive timeline →
Synmol Biosciences Private Limited
Premium access

Shareholding and investment profile for Suresh Ramprabhu Bhosale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Ramprabhu Bhosale

Suresh Ramprabhu Bhosale currently holds 1 directorship: Synmol Biosciences Private Limited (Director, since 29 Apr 2025).

Suresh Ramprabhu Bhosale was first appointed on 29 Apr 2025 as Director at Synmol Biosciences Private Limited.

The current boards of Suresh Ramprabhu Bhosale's companies include Abhishek Anil Bhoyar (Synmol Biosciences Private Limited), Aditya Harne (Synmol Biosciences Private Limited), Kantilal Babulal Ade (Synmol Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available